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Implication for health policy/practice/research/medical education:
The extract and fractions of A. boonei are not only toxic, but also recovery from the toxic effects is also not within a short-term 
limit. Hence, in general the safety of herbs must be considered when using them for therapeutic and prophylactic purposes.
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Introduction: Toxic effects arising from the use of medicinal herbs have been frequently 
overshadowed by the therapeutic efficacy of phytomedicines. This study was carried out to 
assess the safety of extract and fractions of Alstonia boonei (de wild) stem bark, popularly 
used in the treatment of malaria especially in Africa. 
Methods: Rats were orally exposed to different doses (200 and 400 mg/kg body weight) of 
methanol extract (ME), n-hexane (HF), chloroform (CF), ethylacetate (EF) and aqueous 
fractions (AF) of A. boonei for 7 days. Furthermore, 10 mg/ kg body weight (bw) of chloroquine 
(CQN) was administered as standard drug for 7 days while, 5% tween 80 (TT) and distilled water 
(TW) were administered as control for 7 days. Group I (treatment group) was sacrificed after 
7 days while group II (recovery group) was left for 21 days to recover and thereafter sacrificed. 
The effects of treatment and recovery were analyzed using serum biomarkers, hematological 
parameters and tissue histopathological evaluation. 
Results: There was reduction in hematological parameters after 7 days but recovered 
after 21 days. There was also increase in serum alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) and alkaline phosphatase (ALP), after 7 days. Compared to TW and 
TT treated groups, histopathological scores of liver and kidney were critical for all groups at 400 
mg/kg  bw after 21 days. 
Conclusion: The animals did not fully recover after 21 days, suggesting that 400 mg/kg bw 
of extract and fractions of A. boonei were both hepatotoxic and nephrotoxic. Hence this plant 
should be used with caution.
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Introduction
Plants are cheap sources of medicinal intervention both 
for curative and preventive measures. In African and Asian 
continents, a greater percentage of the entire population 
relies solely on phytomedicine because of their folkloric 
and high efficiency. Herbs are prepared as infusion of a 
mixture of plants, a whole plant or plant parts containing 
phytochemical components some of which may not 
be necessary for the reasons why the decoction was 
prepared. Alstonia boonei (de wild), a deciduous plant of 
the Apocynaceae family is well known for its antimalarial 
activity and other therapeutic efficacies. The folkloric use 
of this plant for therapeutic and prophylactic antimalarial 
purposes has been justified with scientific research (1,2).
A herbal medicine may be taken in a toxic dose because 
of self-treatment (3), management and preparation of 
the phytomedicine by unqualified practitioners (4), 
substandard phytomedical products and the presence of 
heavy metals and toxins in the herbal decoctions (5) and/
or improper intake (6). Herbal drugs may be nephrotoxic 
(7), hepatotoxic (8), cardiotoxic (9) or neurotoxic (10). 
It has been reported that Africans that are vulnerable to 
kidney diseases are mostly those that rely on traditional 
medicines and that herbal medicines account for about 
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30%-35% of acute kidney diseases in Africa (11). Because 
of its central role in metabolizing herbs and herbal 
products ingested, the liver is one of the internal organs 
affected directly by herbs or indirectly by their metabolites 
(12). While some common plants used as herbal medicines 
have shown clinical signs of cardiotoxicity due to their 
adverse effects on some cardiac events such as blood 
pressure and inflammation of myocardium, some have 
neurotoxic effects (10,13). Few researches have been done 
to assess the toxicity of A. boonei. The ethanol extract of 
A. boonei stem bark might be toxic when co-administered 
with DDVP (2, 2-dichlorovinyl dimethyl phosphate) (14). 
However, there is paucity of information on the duration of 
recovery from the toxic effects of administration of various 
solvent fractions of the stem bark extract or if a permanent 
damage is to be established as a result of the toxicity of 
this plant. Besides, the doses of extract and fractions of 
A. boonei used in this work and duration have been used 
in antimalarial works (1,2) and so it is a representative of 
expected toxicity of such experimental design. It is against 
this background that we assessed the toxic effects of oral 
administration of extracts and fractions of A. boonei and 
levels of recovery after 21 days of drug withdrawal.
Materials and Methods
Chemicals
Methanol, n-hexane, chloroform  and ethylacetate were 
obtained from Sigma-Aldrich chemicals, St. Louis MO, 
USA; chloroquine phosphate was obtained from Jopan 
Pharmaceuticals Nig. Ltd, Ajao Estate, Lagos Nigeria; 
Alnine and aspartate aminotransferases assay kits were 
obtained from Randox laboratories ltd. (Antrim, UK). All 
other chemicals used were of analytical grade and were 
obtained from British Drug Houses (Poole, Dorset, UK).
Plant material
Stem bark peels of A. boonei were obtained from Ekiti 
State University, Nigeria and were identified by Mr. 
Omotayo, F.O. of the University Herbarium, Ekiti State 
University and a voucher number (UHAE013) was 
assigned to the sample. The peels were washed and air-
dried in the laboratory for 3 weeks after which they were 
pulverized, and soaked in methanol for 3 days. The filtrate 
was concentrated using rotary evaporator (Stuart, UK) to 
yield a dark brown methanol extract (ME).
Partitioning of the methanol extract
Methanol extract (50 g) was mixed with 250 mL of 
distilled water and partitioned successively between 
n-hexane, chloroform and ethylacetate to yield hexane 
(HF), chloroform (CF), ethylacetate (EF) and aqueous 
fractions (AF) using a separating funnel. These were 
concentrated using rotary evaporator and were further 
concentrated in water bath at 40°C until constant weights 
were obtained. In this way, the solvents were removed and 
the dry fractions were stored in the refrigerator until used.
Animals 
Seventy male rats (100-120 g) were obtained from the 
Central Animal House, College of Medicine, University of 
Ibadan, Nigeria and were broadly divided into two groups 
of thirty-five animals each for the acute and recovery 
experiments. Each fraction, extract, chloroquine and 
untreated control group had five animals each. Similar 
animal groupings were used for the recovery experiment. 
The animals were housed in clean cages and had access 
to clean water and standard rat pellets (Ladokun Feeds, 
Nigeria) ad libitum. 
Animal treatment and sample collection
The animals were exposed to 200 and 400 mg/kg bw doses 
of ME, HF, CF, EF AF and 10 mg/kg bw of chloroquine 
(CQN) orally, once daily for 7 days. The untreated control 
group received the vehicle -- water (TW) and 5% v/v 
tween 80 (TT) for those days. After 7 days, the acute 
treated groups were sacrificed via cervical dislocation, 
opened up and blood was collected from the heart into 
plain sample bottles, spun at 3000 rpm for 5 minutes and 
the serum was collected into another plain bottle. The 
recovery groups were left for 21 days without treatment 
and sacrificed after an overnight fast. Liver and kidney 
sections used for histopathology were excised and fixed in 
ten percent formalin until used.
Biochemical assays 
Serum alanine, aspartate aminotransferases (ALT and 
AST) and alkaline phosphatase (ALP) were analyzed 
using Randox kits.
 
Hematological parameters
Packed cell volume (PCV), hemoglobin (Hb), total 
white blood cell count (TWBC), neutrophils (N), and 
lymphocytes (L) were estimated according to a previously 
defined method (15). 
Tissue histopathology
The fixed liver and kidney tissues were dehydrated by 
ascending grades of isopropyl alcohol for an hour. The 
dehydrated organs were cleared in xylene and transferred 
into two changes of liquid paraffin wax. The tissue sections 
were stained in Ehrlich’s hematoxylin for 8 minutes, 
washed in water and dipped in acid alcohol to remove 
excess stain. These were counter stained in 10% aqueous 
eosin, incubated and mounted for photomicrography.
Statistical analysis
All values were expressed as mean ± standard deviation 
(SD). Data were analyzed using Duncan’s multiple range 
test and level of significance was set at P < 0.05.
Results
Tables 1 and 2 respectively show the effects of oral 
administration of 200 mg/kg bw of the extract and 
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fractions of the methanol stem bark extract of A. boonei 
on blood parameters. The PCV, TWBC, Hb and L values 
increased albeit insignificantly after a recovery period of 
21 days among groups administered with ME, HF, CF, EF 
and CQN while there was no significant difference when 
values of the hematological parameters were compared 
among the extract and fractions. In all these parameters, 
animals treated with water (TW) had the highest values 
both after 7 days treatment and 21 days recovery except 
in TWBC. 
Tables 3 and 4 respectively show the effects of the extract 
and fractions of the methanol stem bark extract of A. 
boonei on some hematological parameters at 400 mg/
kg bw dose after 7 days treatment and 21 days recovery 
period. The results obtained showed a similar trend with 
200 mg/kg bw dose but with severe and critical effects. 
Biochemical studies on AST, ALT and ALP activities 
(Tables 5, 6, 7 and 8) at 200 and 400 mg/kg bw dose of 
A. boonei extract and fractions showed that the enzyme 
activities increased dose dependently with maximal effect 
noticed in the CF group. There was no significant decrease 
in the activities of these enzymes after 21 days. 
Histopathological studies (Figure 1) revealed the lesions 
both in the liver and kidney of animals treated with 400 
Table 1. Hematological effects of 200 mg/kg bw of extract and fractions of Alstonia boonei in rats after 7 days 
Drugs PCV (%) TWBC (cumm-1) Hb (g/dL) N (%) L (%)
ME 38.50a±4.93 5975.00a±1078.19 12.65a±1.70 14.75ab±6.07 85.00a±6.37
HF 36.00a±4.24 5350.00a±1799.07 11.97a±1.39 26.00ab±9.34 73.50a±9.03
CF 34.25a±4.34 4500.00a±1000.00 11.35a±1.39 30.75b±14.17 71.25a±12.09
EF 35.50a±4.04 6750.00b±613.73 11.80a±1.33 23.25ab±9.21 76.00a±9.20
AF 37.00a±4.08 5600.00a±1564.18 12.05a±1.02 12.75ab±2.42 87.25a±12.41
TW 40.00b±8.49 6500.00b±282.84 13.30a±1.61 14.50ab±6.36 89.50a±15.90
CQN 34.25a±8.96 4600.00a±743.86 12.03a±1.61 11.50a±3.79 88.50a±4.03
TT 37.50a±2.65 4725.00a±1791.42 12.42a±0.89 20.25ab±5.35 78.75a±6.36
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction (CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with water only 
(TW); Chloroquine (CQN);  Tween 80 (5% v/v) only (TT); Packed cell volume (PCV); Total white blood cell (TWBC); Hemoglobin (Hb); Neutrophil (N); 
Lymphocyte (L). Values are mean of five determinations ± standard deviation. Values with different superscripts within the column are significantly 
different at P < 0.05.
Table 3. Hematological effects of 400 mg/kg bw of extract and fractions of Alstonia boonei in rats after 7 days
Drugs PCV (%) TWBC (cumm-1) Hb (g/dL) N (%) L (%)
ME 39.00a±2.82 5325.00a±1650 12.95a±0.96 24.73a±3.40 74.25a±3.30
HF 38.50a±4.12 6200.00a±983.19 12.82a±1.36 17.50a±1.63 74.75a±4.73
CF 32.25a±4.03 5900.00a±2824.89 10.72a±1.33 13.50a±1.18 85.75a±5.11
EF 31.50a±5.80 5925.00a±1740.45 10.42a±1.99 26.25ab±1.90 72.75a±10.53
AF 34.00a±1.41 4950.00a±1791.42 11.32a±0.47 27.75a±1.08 71.50a±9.77
TW 40.00b±8.49 6500.00b±282.84 13.30a±1.61 14.50ab±6.36 89.50a±15.90
CQN 34.25a±8.96 4600.00a±743.86 12.03a±1.61 11.50a±3.79 88.50a±4.03
TT 37.50a±2.65 4725.00a±1791.42 12.42a±0.89 20.25ab±5.35 78.75a±6.36
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction (CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with water only 
(TW); Chloroquine (CQN);  Tween 80 (5% v/v) only (TT); Packed cell volume (PCV); Total white blood cell (TWBC); Hemoglobin (Hb); Neutrophil (N); 
Lymphocyte (L). Values are mean of five determinations ± standard deviation. Values with different superscripts within the column are significantly 
different at P < 0.05.
Table 2. Hematological effects of 200 mg/kg bw of extract and fractions of Alstonia boonei in rats after 21 days 
Drugs PCV (%) TWBC (cumm-1) Hb (g/dL) N (%) L (%)
ME 41.25b±2.63  6675.00a±665.21 13.73b±0.8 5.50b±2.38       90.25a±2.62
HF 33.50a±7.3  7675.00b±607.59 11.13b±2.41 13.25a±11.35 86.00a±12.11
CF 38.00b±0.81 6775.00ab±2085.47 12.63b±0.29 8.50b±8.06 91.50a±8.06
EF 41.75b±0.96 8075.00b±991.21 13.88b±0.34 12.50a±3.87 87.50a±3.87
AF 34.00a±6.38 6650.00ab±2389.56 11.30b±0.34 15.75a±4.92 84.00a±5.23
TW 46.00b±0.00 6700.00ab±0.00 15.60a±0.00 7.00b±0.00 93.50a±0.00
CQN 40.00b±4.32 4675.00 a±1379.31 13.30b±1.44 6.25a±5.18 93.00a±5.68
TT 37.00b±6.27 7400.00b±1557.78 12.30b±2.12 10.00a±5.29 91.00a±6.06
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction (CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with water only 
(TW); Chloroquine (CQN);  Tween 80 (5% v/v) only (TT); Packed cell volume (PCV); Total white blood cell (TWBC); Hemoglobin (Hb); Neutrophil (N); 
Lymphocyte (L). Values are mean of five determinations ± standard deviation. Values with different superscripts within the column are significantly 
different at P < 0.05.
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mg/kg bw of the drug candidates after 21 days. The results 
obtained showed that there was portal congestion (ME), 
diffuse vacuolar degeneration (HF, EF CQN and AF), and 
severe diffuse hepatic vacuolation with central venous 
Table 4. Hematological effects of 400 mg/kg bw of extract and fractions of Alstonia boonei in rats after 21 days
Drugs PCV (%) TWBC (cumm-1) Hb (g/dL) N (%) L (%)
ME 42.333a±1.52 5633.33a±981.49 14.06b±0.50 10.67a±2.08 88.69a±3.21
HF 39.25b±2.22 7625.00ab±1102.65 13.05b±0.71 8.75a±6.80 91.00a±7.25
CF 41.00a±1.41 9200.00b±1414.21 13.65b±0.49 19.00a±2.21 80.50a±21.92
EF 39.00b±1.83 5900.00a±2426.25 12.95b±0.34 17.25a±14.89 82.50a±14.02
AF 37.33b±2.31 6666.67ab±1553.49 12.43b±0.75 11.00a±2.00 89.00a±2.02
TW 46.00b±0.00 6700.00ab±0.00 15.60a±0.00 7.00b±0.00 93.50a±0.00
CQN 40.00b±4.32 4675.00 a±1379.31 13.30b±1.44 6.25a±5.18 93.00a±5.68
TT 37.00b±6.27 7400.00b±1557.78 12.30b±2.12 10.00a±5.29 91.00a±6.06
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction (CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with water only 
(TW); Chloroquine (CQN);  Tween 80 (5% v/v) only (TT); Packed cell volume (PCV); Total white blood cell (TWBC); Hemoglobin (Hb); Neutrophil (N); 
Lymphocyte (L). Values are mean of five determinations ± standard deviation. Values with different superscripts within the column are significantly 
different at P < 0.05.
Table 6. Effects of 200 mg/kg bw of extract and fractions of 
Alstonia booneion AST, ALT and ALP after 21 days
Drugs ALT (U/L) AST (U/L) ALP (U/L)
ME 117.90ab±7.14 52.11ab±22.00 200.01a±5.86
HF 80.13a±3.24 33.00a±6.90 218.04a±10.73
CF 120.88c±0.07 60.42c±7.90 220.12b±3.14
EF 110.20c±3.14 49.09abc±2.41 190.14d±0.00
AF 106.90bc±3.14 47.00ab±2.91 215.11b±3.20
TW 44.21c±0.00 45.00ab±0.00 78.04a±0.00
CQN 96.41ab±7.71 32.01a±7.81 476.50c±5.99
TT 46.21c±9.36 36.11ab±14.82 53.44a±2.93
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction 
(CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with 
water only (TW); Chloroquine (CQN); Tween 80 (5% v/v) only (TT); 
Aspartate aminotransferase (AST); Alanine aminotransferase (ATL); 
alkaline phosphatase (ALP). Values are mean of five determinations ± 
standard deviation. Values are mean of five determinations ± standard 
deviation. Values with different superscripts within the column are 
significantly different at P < 0.05.
Table 5. Effects of 200 mg/kg bw of extract and fractions of 
Alstonia booneion AST, ALT and ALP after 7 days
Drugs ALT (U/L) AST (U/L) ALP (U/L)
ME 120.70ab±10.14 57.20bcd±2.47 220.81a±28.61
HF 83.03a±8.25 33.72a±2.09 227.03ab±20.49
CF 126.83b±8.34 61.16cd±9.82 243.57ab±20.49
EF 115.20±6.25 53.44abcd±8.92 200.19a±44.46
AF 110.78ab±3.90 48.20abc±3.25 222.18a±6.11
TW 46.25c±3.18 48.24abcd±3.62 75.90a±0.74
CQN 98.55ab±2.73 40.68abc±3.98 517.50ab±13.21
TT 40.95c±7.33 37.24ab±8.82 51.75a±6.83
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction 
(CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with 
water only (TW); Chloroquine (CQN); Tween 80 (5% v/v) only (TT); 
Aspartate aminotransferase (AST); Alanine aminotransferase (ATL); 
alkaline phosphatase (ALP). Values are mean of five determinations ± 
standard deviation. Values are mean of five determinations ± standard 
deviation. Values with different superscripts within the column are 
significantly different at P < 0.05.
Table 7. Effects of 400 mg/kg bw of extract and fractions of 
Alstonia booneion AST, ALT and ALP after 7 days
Drugs ALT (U/L) AST (U/L) ALP (U/L)
ME 127.95ab±16.85 58.84abc±5.69 302.82a±9.73
HF 121.35ab±29.3 52.92b±13.06 448.64abc±4.39
CF 130.13b±9.36 81.68abc±10.41 536.65bc±1.99
EF 123.23±6.07 58.92b±14.02 250.65abc±1.99
AF 121.73abc±4.28 49.12ab±7.16 445.91a±11.28
TW 46.25c±3.18 48.24abcd±3.62 75.90a±0.74
CQN 98.55ab±2.73 40.68abc±3.98 517.50ab±13.21
TT 40.95c±7.33 37.24ab±8.82 51.75a±6.83
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction 
(CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with 
water only (TW); Chloroquine (CQN); Tween 80 (5% v/v) only (TT); 
Aspartate aminotransferase (AST); Alanine aminotransferase (ATL); 
alkaline phosphatase (ALP). Values are mean of five determinations ± 
standard deviation. Values are mean of five determinations ± standard 
deviation. Values with different superscripts within the column are 
significantly different at P < 0.05.
congestion (CF) after 21 days. The kidney showed few 
tubules with protein cast (ME and HF), and moderate 
renal cortical congestion (EF and AF). The kidney section 
of the CF showed marked renal cortical congestion and 
hemorrhage.
Discussion
Malaria is a fatal parasitic infection especially in the 
tropical African and Asian continent and it is believed 
that it kills more than AIDS and the most vulnerable are 
children under the age of 5 years (16). Herbal remedy, 
which in most cases, is a combination of two or more 
plants is usually taken ad libitum for the treatment or 
prevention of malaria in Africa. This good intention but 
with fatal consequences has its deleterious effects in terms 
of toxicities. The results obtained showed that PCV, Hb, 
and TWBC decreased after 7 days but slightly increased 
after 21 days. The significant decrease in PCV observed in 
the HF and AF groups showed that these fractions might 
contain phytochemicals capable of causing hemolytic 
anemia possibly via the destabilization of the erythrocyte 
membrane (17,18). The observed significant decrease in 
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Hb of the test groups compared with the animals treated 
with water (TW) showed that the extract and fractions 
interfered with oxygen carrying capacity of blood cells or 
that the administration of the drug candidates impaired 
erythropoiesis (19). The significant increase in TWBC 
levels after 21 days compared with its levels after 7 days 
could be as a result of phytochemicals eliciting immune 
response to chemicals or as a result of secondary infections 
(20).
The reduction in the levels of neutrophils after the 
withdrawal of the drug candidates indicated that the 
extract and fractions repressed neutrophil production 
or enhanced its destruction maybe to minimize cellular 
injury because in addition to their immune response, 
Table 8. Effects of 400 mg/kg bw of extract and fractions of 
Alstonia booneion AST, ALT and ALP after 21 days
Drugs ALT (U/L) AST (U/L) ALP (U/L)
ME 120.01abc±11.34 50.10c±15.61 200.49d±10.03
HF 100.01bc±38.12 39.40bc±21.27 341.42bc±4.98
CF 126.40ab±30.33 70.62c±4.29 490.04ab±4.87
EF 119.00c±19.34 47.48ab±9.92 200.41c±9.75
AF 115.90a±43.05 40.44ab±21.48 296.11b±8.78
TW 44.21c±0.00 45.00ab±0.00 78.04a±0.00
CQN 96.41ab±7.71 32.01a±7.81 476.50c±5.99
TT 46.21c±9.36 36.11ab±14.82 53.44a±2.93
Methanol extract (ME); n-Hexane fraction (HF); Chloroform fraction 
(CF); Ethylacetate fraction (EF); Aqueous fraction (AF); Treated with 
water only (TW); Chloroquine (CQN); Tween 80 (5% v/v) only (TT); 
Aspartate aminotransferase (AST); Alanine aminotransferase (ATL); 
alkaline phosphatase (ALP). Values are mean of five determinations ± 
standard deviation. Values are mean of five determinations ± standard 
deviation. Values with different superscripts within the column are 
significantly different at P < 0.05.
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Figure 1. Histopathology of liver and kidney tissue sections of rats exposed to 400mg/kg of ME (A),  HF (B), EF (C), AF (D), CQN (E) 
and CF (F) after 21 days of recovery. The result showed hepatic vacuolation ( black stars in A), severe portal congestion with cellular 
infiltration by mononuclear cells and mild fibroplasias (blue arrows in C and D). The kidney sections of the same treated groups (G-L 
respectively) showed renal cortical congestion and tubules with protein casts (black arrows in G) and hemorrhage (blue arrows in J and L). 
ME= Methanol Extract, CQN= Chloroquine, HF, CF, EF and AF are n-hexane, chloroform, ethylacetate and aqueous fractions respectively.
neutrophils are implicated in tissue damage (21). An 
increase in the lymphocyte values showed that the 
extract and fractions enhanced the proliferation. This 
showed that the extract and fractions of A. boonei 
had immunosuppressive effects on neutrophils and 
immunostimulatory on lymphocyte proliferation. Some 
herbal preparations have immunomodulatory effects 
like this (22). The hematological parameters did not fall 
below a threshold which could pose danger to the animals, 
however, an increase in these hematological parameters 
following the withdrawal of the drug candidates showed 
that oral administration of the extract and fractions had 
reducing effects on them. A basal level of AST and ALT 
is found in the plasma which may increase when there is 
damage to tissues such as liver, kidney and heart. Increase 
in the serum level of ALP indicates liver injury or hepatitis 
(23). The reference values for AST (0 to 40 U/L) and 
ALT (0 to 45 IU/L) in human (24) showed that all values 
obtained for these enzymes from all the drug candidates at 
both doses and at 7 and 21 days were significantly higher 
than normal and it was evidently clear that damage was 
done to the liver. The increase in the activities of these 
enzymes after 7 days is indicative of the toxic effects of the 
extract and fractions of the stem bark extract of A. boonei. 
Subsequent decrease in the serum activities of these 
enzymes after 21 days did not reveal complete recovery. 
Microscopic examination of the liver and kidney sections 
after the recovery period of 21 days showed various 
lesions such as vacuolar degeneration, portal cellular 
infiltration by mononuclear cells and severe, diffuse 
hepatic vacuolation with central venous congestion, 
diffuse hepatic vacuolation and severe portal congestion 
with cellular infiltration by mononuclear cells and mild 
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fibroplasias, renal cortical congestion and hemorrhage. 
The congestion observed in the liver is evidence that the 
liver is involved in the biotransformation of xenobiotics. 
The kidney is an organ for excretion; therefore, it is exposed 
to both metabolized and un-metabolized toxicant for their 
removal from the body; the heavy task for the removal 
of toxicant from the body may cause much damage for 
the kidney. Again, some herbs may contain compounds 
such as oxalate which may chelate calcium and thus cause 
kidney stone. This means that high dose of extract and 
fractions of the methanol stem bark extract of A. boonei 
is both hepatotoxic and nephrotoxic and 21 days after the 
withdrawal of the drug did not give complete recovery. 
However, treatment of the negative control groups with 
water (TW) and 5% v/v (TT) did not show any noticeable 
effects on the hematological parameters, marker enzymes 
and histological evaluation.
Conclusion
Taking together, the results obtained from this research 
work suggested a moderate intake of herbal formulation 
for the treatment of diseases because of the possible side 
effects. The extract and fractions of A. boonei are not only 
toxic, but also recovery from the toxic effects is not within 
a short-term limit. Although, administration of herbal 
medicines may be useful in the treatment of diseases, the 
secondary adverse effects must not be overlooked because 
in some cases, these side effects are more deleterious than 
the diseases these phytochemicals are originally used to 
treat. In conclusion, the safety of the administration of 
herbs must be considered when using them for therapeutic 
and prophylactic purposes.
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